Health Care/Hospital

Innovative and Eco-friendly Masks to Provide Silver Lining for Declining Consumer Face Mask Market

For face mask businesses to thrive in the post-COVID-19 era, manufacturers must develop masks with distinct product features, says Frost & Sullivan SANTA CLARA, Calif., April 22, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis on the global consumer face mask market finds that the mature ...

2021-04-22 04:03 1735

endpoint Launches ConnectionPOINT™ - A partnership program designed to power accelerated outcomes and move medicine through next-generation eClinical technology interfacing

SAN FRANCISCO, April 21, 2021 /PRNewswire/ -- endpoint Clinical, the leading global interactive response technology (IRT®) company, announced today the launch of their partnership program,ConnectionPOINT™, the first of its kind in the eClinical technology space.  The program's vision is for a g...

2021-04-21 21:00 2853

Mount Sinai Hospital in New York joins RhoVac's Phase IIb Study in Prostate Cancer

STOCKHOLM, April 21, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,April 21st 2021, that the prestigiousMount Sinai hospital in New York is initiated today as the latest addition to US trial centres in RhoVac's clinical phase IIb study, "BRaVac...

2021-04-21 20:56 1750

Cobots Lead the Future of the Global Industrial Robots Market, Finds Frost & Sullivan

Asia-Pacific to remain the epicenter of growth opportunities for robot manufacturers, with market revenues estimated to top$25.08 billion by 2024 SANTA CLARA, Calif., April 21, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that theglobal industrial robotics market will reach reven...

2021-04-21 20:48 2238

ATH434 protects brain cells and improves motor function in Parkinsonian disorder

MELBOURNE, Australia , April 21, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced an oral presentation of expanded animal data to support the commercialisation of its lead compound ATH434 in clinical development for the treatment of...

2021-04-21 20:11 2250

Seed Health Closes $40 Million in Series A Financing to Launch New Categories, Accelerate Global Distribution and Expand Clinical Research

LOS ANGELES, April 21, 2021 /PRNewswire/ -- Seed Health, a microbial sciences company developing next-generation probiotic applications and live biotherapeutics, today announced the close of a $40 million Series A financing led by impact investor,The Craftory, alongside TechBio investor ARTIS Ven...

2021-04-21 20:00 2730

111 to Announce First Quarter 2021 Unaudited Financial Results on May 19, 2021 - Conference Call to Follow

SHANGHAI, April 21, 2021 /PRNewswire/ – 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial results...

2021-04-21 20:00 2088

Seed Health Closes $40 Million in Series A Financing to Launch New Categories, Accelerate Global Distribution and Expand Clinical Research

LOS ANGELES, April 21, 2021 /PRNewswire/ -- Seed Health, a microbial sciences company developing next-generation probiotic applications and live biotherapeutics, today announced the close of a $40 million Series A financing led by impact investor,The Craftory, alongside TechBio investor ARTIS Ven...

2021-04-21 20:00 1368

Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."

INCHEON, South Korea, April 21, 2021 /PRNewswire/ -- Samsung Biologics, the world's leading contract development and manufacturing organization, celebrated the 10th anniversary of its founding today at its global headquarters in Songdo, Incheon via a virtual ceremony.

2021-04-21 19:00 1335

#RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month

- Rosacea sufferers join forces this Rosacea Awareness Month to bravely share the personal impact essential COVID-19 mask-wearing has on their skin condition - #RosaceaUnmasked encourages rosacea sufferers to speak with a doctor or dermatologist about the burden of regular mask-wearing on their r...

2021-04-21 17:29 1890

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on April 28 at 9:30 CET

STOCKHOLM, April 21, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFOElisabet Lund. To register for the presentation of the...

2021-04-21 17:07 1001

Leapstack Announces Strategy to Actively Fuel Expansion in South Korean Market

SHANGHAI, April 21, 2021 /PRNewswire/ -- Leapstack (or "the Company"), an AI-enabled InsurTech company specializing in healthcare, announced a strategic plan to ink strategic partnerships with multiple Korean insurance companies as the Company actively advances into the South Korean market having...

2021-04-21 13:12 2059

GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme

SINGAPORE, April 21, 2021 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK)'s biopharmaceutical CDMO segment, GenScript ProBio announced a collaboration with the Experimental Drug Development Centre (EDDC),Singapore's national platform for drug discovery and development, on an a...

2021-04-21 11:08 4706

Ascentage Pharma to Announce Results from Four Clinical Studies at 2021 ASCO Annual Meeting, with Data of Its Drug Candidates Including Lisaftoclax (APG-2575) to Be Released in Oral Presentations for the First Time

SUZHOU, China and ROCKVILLE, Md., April 21, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that results from four clin...

2021-04-21 08:38 2320

Clinical Trial Industry Veteran Paul Malan Joins Bioforum as Vice President of Biostatistics

NESS ZIONA, Israel, April 21, 2021 /PRNewswire/ -- Bioforum , a data-focused contract research organization (CRO) serving life sciences organizations worldwide, today announced thatPaul Malan has joined the company as Vice President of Biostatistics. In this new role,...

2021-04-21 06:00 1611

China Biologic Announces Completion of Going Private Transaction

BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced the completion of its merger (the "Merger") with CBPO Group Limited ("Merger...

2021-04-21 04:30 4518

Park Systems, World Leading Atomic Force Microscopy Manufacturer Hits 1 Trillion KRW Mark at KOSDAQ

SANTA CLARA, Calif., April 21, 2021 /PRNewswire/ -- Park Systems, world leading manufacturer of Atomic Force Microscopes announced the companystock valuation exceeded1 Trillion KRW (almost $1 Billion USD) at the end of KOSDAQ on April 5, 2021.  Park Systems issued 1 million shares for its initial...

2021-04-21 03:58 1653

Havas Health & You Bolsters Cloud-Based Client Solutions by Becoming the First Global Content Partner within Veeva Systems' Content Partner Program

NEW YORK, April 20, 2021 /PRNewswire/ -- Digital health has reached record-breaking funding this past year. In 2018, the market was valued at$8.5 billion, and by 2025, it is expected to grow to more than $55 billion according to Global Market Insights. Officially in the era of digitized medicine,...

2021-04-20 21:30 1652

iHerb Opens Its Sixth Fulfillment Center in Hong Kong

PASADENA, Calif., April 20, 2021 /PRNewswire/ -- iHerb is pleased to announce the opening of its sixth fulfillment center. Located inHong Kong, it will be the company's second overseas and will serveMainland China, Hong Kong, Japan, Malaysia, Singapore, and Thailand. The fulfillment center will c...

2021-04-20 21:00 3306

Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005

SUZHOU, China, April 20, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced that it has received clearance of i...

2021-04-20 20:54 1018
1 ... 531532533534535536537 ... 809